No Data
No Data
Press Release: Algernon Pharmaceuticals Announces Closing of Private Placement
Express News | Algernon Pharmaceuticals Inc: Announces Non-Brokered Private Placement for Gross Proceeds of $250,000 at Issue Price of $0.12 per Unit
Algernon Pharmaceuticals Engages ICP Securities Inc. for Automated Market Making Services
Algernon NeuroScience and the Centre for Human Drug Research to Present DMT Phase 1 Stroke...
Algernon Pharmaceuticals CEO Christopher J. Moreau to Be Featured on Radius Research's Pitch,...
Algernon Pharmaceuticals to Move Forward With Psychedelic Drug DMT Stroke Research Program as Its...
No Data